If adverse reactions observed in a blood donor or in a recipient are likely to be due to a product mentioned in II of article L. 5311-1 falling within the scope of another vigilance, a copy of the adverse reaction report form for this donor or recipient is sent by the haemovigilance and transfusion safety correspondent to the correspondent for the vigilance concerned.